Fertility and Sterility
Volume 82, Issue 2 , Pages 300-301, August 2004

Ten years of preimplantation genetic diagnosis-aneuploidy screening: Review of a multicenter report

  • David L Hill, Ph.D.

      Affiliations

    • ART Reproductive Center, Beverly Hills, California, USA
    • Corresponding Author InformationReprint requests: David L. Hill, Ph.D., ART Reproductive Center, 450 N. Roxbury Dr., Beverly Hills, California 90210, USA (FAX: 310-246-4626).

Received 25 November 2003; received in revised form 25 November 2003; accepted 25 November 2003.

Abstract 

Preimplantation genetic diagnosis of day 3 human embryos by fluorescent in situ hybridization has over the past 10 years increased in use as a screen for aneuploidy. Routine screening of preimplantation embryos to increase implantation rates awaits further refinements in handling techniques and testing assays.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0015-0282(04)00874-X

doi:10.1016/j.fertnstert.2003.11.063

Fertility and Sterility
Volume 82, Issue 2 , Pages 300-301, August 2004

Article Tools